{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:31:52Z","timestamp":1790231512574,"version":"4.1.0"},"reference-count":26,"publisher":"Xia & He Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gene expr"],"published-print":{"date-parts":[[2017,2,10]]},"abstract":"<jats:p>African Americans (AAs) have higher hepatocellular carcinoma (HCC) mortality rates than Caucasian Americans (CAs). Chronic hepatitis C virus (HCV) infection leads to cirrhosis and HCC. HCV infection is highly prevalent in the AA population compared to other racial groups. AAs are also\n less likely to naturally clear HCV, potentially contributing to higher prevalence of HCV. However, the explanation for this disparity is currently unknown. Circulating microRNAs (miRNAs) in the blood are emerging as biomarkers for pathological conditions. Expression analysis of miRNAs in major\n racial groups would be important for optimizing personalized treatment strategies. Here we assessed the differential expression of circulatory miRNAs from HCV-infected AA and CA patients. We identified increased expression of miR-146a, miR-150, and miR-155 in HCV-infected AA patient sera compared\n to that of CA. Further analysis demonstrated that these miRNAs were significantly elevated in AA patients diagnosed with HCV-mediated HCC. Higher expression of miR-150 was also noted in cirrhosis and HCC in AA patients, which may serve as a predictor of liver disease progression in this population.\n The differential expression of miRNAs suggests that these miRNAs and their target genes could be useful to gain further mechanistic insight of racial disparity associated with HCV-mediated pathogenesis.<\/jats:p>","DOI":"10.3727\/105221616x693594","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T03:31:40Z","timestamp":1477020700000},"page":"89-98","source":"Crossref","is-referenced-by-count":17,"title":["Differential Expression of MicroRNAs in Hepatitis C Virus-Mediated Liver Disease Between African Americans and Caucasians: Implications for Racial Health Disparities"],"prefix":"10.14218","volume":"17","author":[{"given":"Pradip B.","family":"Devhare","sequence":"first","affiliation":[{"name":"Department of Pathology, Saint Louis University, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian M.","family":"Di Bisceglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna B.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/ajg.2014.243","article-title":"Hepatitis C in African Americans","volume":"109","year":"2014","journal-title":"Am J Gastroenterol."},{"key":"b2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cgh.2013.06.006","article-title":"Hepatitis B and C in African Americans: Current status and continued challenges","volume":"12","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"b3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"b4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.gastro.2011.07.028","article-title":"Model systems for hepatitis C research: The cup half empty?","volume":"141","year":"2011","journal-title":"Gastroenterology"},{"key":"b5","first-page":"977","article-title":"Hepatitis C virus infection: Establishment of chronicity and liver disease progression","volume":"13","year":"2014","journal-title":"EXCLI J."},{"key":"b6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gendis.2015.01.001","article-title":"MicroRNAs: Role in hepatitis C virus pathogenesis","volume":"2","year":"2015","journal-title":"Genes Dis."},{"key":"b7","article-title":"MicroRNAs: Emerging novel targets of cancer therapies","volume":"2015","year":"2015","journal-title":"BioMed Res Int."},{"key":"b8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4254\/wjh.v5.i9.479","article-title":"Hepatitis C virus infection, microRNA and liver disease progression","volume":"5","year":"2013","journal-title":"World J Hepatol."},{"key":"b9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"b10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3892\/ijo.2014.2469","article-title":"Differential expression of miRNAs in colon cancer between African and Caucasian Americans: Implications for cancer racial health disparities","volume":"45","year":"2014","journal-title":"Int J Oncol."},{"key":"b11","doi-asserted-by":"crossref","first-page":"e13735","DOI":"10.1371\/journal.pone.0013735","article-title":"A Pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"b12","first-page":"145","article-title":"Differential expression of microRNAs in papillary thyroid carcinoma and their role in racial disparity","volume":"7","year":"2015","journal-title":"J Cancer Sci Ther."},{"key":"b13","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/1055-9965.EPI-08-0980","article-title":"Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma","volume":"18","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"b14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.26296","article-title":"Upregulation of circulating miR-20a is correlated with hepatitis C virus mediated liver disease progression","volume":"58","year":"2013b","journal-title":"Hepatology"},{"key":"b15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2014.09.001","article-title":"Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy","volume":"81","year":"2015","journal-title":"Adv Drug Deliv Rev."},{"key":"b16","first-page":"1","article-title":"Immuno-miRs: Critical regulators of T-cell development, function and ageing","volume":"144","year":"2014","journal-title":"Immunology"},{"key":"b17","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or tumor suppressor? The duplicity of microRNAs in cancer","volume":"76","year":"2016","journal-title":"Cancer Res."},{"key":"b18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ol.2015.3170","article-title":"Role of microRNA-150 in solid tumors","volume":"10","year":"2015","journal-title":"Oncol Lett."},{"key":"b19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.yexmp.2015.07.001","article-title":"Circulating levels of miR-150 are associated with poorer outcomes of A\/H1N1 infection","volume":"99","year":"2015","journal-title":"Exp Mol Pathol."},{"key":"b20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/imm.12468","article-title":"Physiological roles of miR-155","volume":"145","year":"2015","journal-title":"Immunology"},{"key":"b21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3892\/or.2013.2453","article-title":"miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis","volume":"30","year":"2013","journal-title":"Oncol Rep."},{"key":"b22","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1007\/s13277-014-1688-4","article-title":"Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro","volume":"35","year":"2014","journal-title":"Tumour Biol."},{"key":"b23","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.25849","article-title":"Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"b24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/hep.27886","article-title":"Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"b25","first-page":"e02459","article-title":"Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H","volume":"6","year":"2015","journal-title":"MBio"},{"key":"b26","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00619-16","article-title":"Hepatitis C virus-induced upregulation of microRNA miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis","volume":"90","year":"2016","journal-title":"J Virol."}],"container-title":["Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/cog\/ge\/2017\/00000017\/00000002\/art00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:16:34Z","timestamp":1783707394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.3727\/105221616X693594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2,10]]}},"alternative-id":["1052-2166(20170210)17:2L.89;1-"],"URL":"https:\/\/doi.org\/10.3727\/105221616x693594","relation":{},"ISSN":["1052-2166"],"issn-type":[{"value":"1052-2166","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}